Found 159 matching trials
Human Upper Extremity Allotransplantation PHASE2 Background: Millions of people each year sustain injuries, have tumors surg...
Show More Location
Johns Hopkins University School of Medicine
Learn More & Join Trial
Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations PHASE1 BDTX-1535-101 is an open-label, Phase 1 dose escalation and Phase 2 multipl...
Show More Status
Active Not Recruiting
Location
University of Alabama
Learn More & Join Trial
A Study of Retreatment With Brentuximab Vedotin in Subjects With Classic Hodgkin Lymphoma or CD30-expressing Peripheral T Cell Lymphoma PHASE2 This study will look at whether brentuximab vedotin works and is safe in th...
Show More Location
Pacific Cancer Medical Center
Learn More & Join Trial
Multi-CAR-T Cells Targeting B Cell Lymphomas PHASE1 This study aims to evaluate safety and efficacy of a combination of 4th gen...
Show More Location
Shenzhen Geno-Immune Medical Institute
Learn More & Join Trial
AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers NA This is a multicenter, randomized, parallel-group study comparing the outco...
Show More Learn More & Join Trial
Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT PHASE2 To evaluate if hyper-fractionated TBI or TMLI followed by Treg/Tcon adoptiv...
Show More Location
University of Perugia
Learn More & Join Trial
CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphoma PHASE1 Patients with poor risk classical Hodgkin Lymphoma (cHL) will undergo myelo...
Show More Location
New York Medical College
Learn More & Join Trial
TCR-engineered T Cells (NW-101C) in Patients With Solid Malignant Tumors PHASE1 This clinical trial is a prospective, dose-escalation, multicenter, single-...
Show More Location
Beijing Cancer hosptial
Learn More & Join Trial
Addition of Chidamide to the Combination Treatment of Decitabine Plus Camrelizumab in Combination Treatment Resistant/Relapsed Patients With Classical Hodgkin Lymphoma PHASE2 This is a Phase II clinical trial for Decitabine plus Camrelizumab resistan...
Show More Location
Biotherapeutic Department of Chinese PLA General Hospital
Learn More & Join Trial
Study of TLR9 Agonist Vidutolimod (CMP-001) in Combination With Nivolumab vs. Nivolumab PHASE2 The main goal of this research study is to determine how nivolumab and nivo...
Show More Location
UPMC Hillman Cancer Center
Learn More & Join Trial